Realheart recruits CTO from German artificial heart start-up
Realheart has recruited a Chief Technology Officer for its headquarters in Västerås, Sweden. Thomas Finocchiaro joins from a similar role at a German company named Reinheart TAH GmbH, which, like
RECOVERY trial finds Regeneron’s monoclonal antibody combination reduces deaths for hospitalised COVID-19 patients who have not mounted their own immune response
The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that the investigational antibody combination developed by Regeneron reduces the risk of death when given to patients hospitalised with severe
Dutch MedTech STENTiT appoints Golo von Basum as Chief Operating Officer
a medical device company bringing a novel class of regenerative stents for sustained endovascular repair, has appointed Dr. Golo von Basum (picture) as its Chief Operating Officer (COO). He will
Ortoma has Agreement on Non-binding Term Sheet for Exclusive Distribution Rights in Japan
Ortoma has agreement on a non-binding term sheet with a major global orthopedics implant and MedTech manufacturer for exclusive distribution rights of the Ortoma Treatment Solution for hip surgery in
Vaccine logistics: Silica from Evonik as part of the cold chain
Minus 70 degrees Celsius. During the COVID-19 pandemic,this figure was coupled to great hopes and significant challenges. Its inextricable link to one of the first mRNA vaccines came about due
Realheart strengthens R&D Team with three engineers
Realheart has recruited a Principal Engineer, a Systems Developer, and a Graduate Engineer to the R&D team at its headquarters in Västerås, Sweden. All will take up their new positions
Kindred partners with EASG to promote safer gambling
Kindred partners with the European Association for the Study of Gambling, EASG, to promote an app that can help identify early signs of gambling addiction to its customers. The Bettor
New adaptable nanoparticle platform enables enhanced delivery of gene therapies, RCSI research
Scientists have developed polypeptide-based materials that act as effective vectors for delivering gene therapies. The first-of-its-kind platform enables the vectors to be adapted to suit the specific gene therapy cargo.
Researchers monitor mRNA to help time its great escape to perfection
The ease by which mRNA-based drugs are taken up by cells in tissues is crucial to their therapeutic effectiveness. Now, a new detection method developed by researchers at Chalmers University
Peter McCarthy joins Argenta as Chief Operating Officer North America
Argenta today announced that Peter McCarthy has been appointed Chief Operating Officer North America, a new executive position within Argenta. Effective immediately, Peter will oversee Argenta’s business operations and strategic